Open AccessObstructive lung diseases burden and COVID-19 in developing countries: a perspective
Author(s) -
Ashutosh N. Aggarwal,
Kuruswamy Thurai Prasad,
Valliappan Muthu
Publication year - 2021
Publication title -
current opinion in pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.937
H-Index - 75
eISSN - 1531-6971
pISSN - 1070-5287
DOI - 10.1097/mcp.0000000000000836
Subject(s) - medicine , covid-19 , perspective (graphical) , betacoronavirus , intensive care medicine , coronavirus infections , medline , lung , virology , environmental health , disease , artificial intelligence , outbreak , infectious disease (medical specialty) , political science , law , computer science
Asthma and chronic obstructive pulmonary disease (COPD) are widely prevalent disorders, and important contributors to morbidity and mortality, in both developing and developed countries. It is conjectured that these obstructive lung diseases may have had more deleterious effects in developing nations during the 2019 coronavirus disease (COVID-19) pandemic. We provide an evidence-based perspective on the relationship between asthma/COPD prevalence and COVID-19 burden, and the impact of comorbid asthma/COPD on selected COVID-19 outcomes and healthcare utilization, with special reference to developing countries.